ENLV logo

Enlivex Therapeutics Ltd. (ENLV)

Profile

Full Name

Enlivex Therapeutics Ltd.

Ticker

NASDAQ: ENLV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

July 31, 2014

Indexes

Not included

Website

https://www.enlivex.com

Employees

71

Key Details

Price

$1.01(1.01%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.73(53.23% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.01
    ENLV price is $1.01

    30-Day Relative Volume

    0.45
    ENLV 30-day relative volume is 0.45

    Price Performance

    Price Most Recent Change

    +1.01%
    ENLV price was up +1.01% on Nov 6, 2025

    Price YTD Change

    -13.68%
    ENLV price is down -13.68% since January 1st

    Price 1-Year Change

    -20.47%
    ENLV price is down -20.47% year-on-year

    Price 3-Year Change

    -76.51%
    ENLV price is down -76.51% over the past 3 years

    Price Range

    Price All-Time High

    $440.00
    ENLV price is currently -99.77% below its historical high of $440.00

    Price 3-Year Low

    $0.81
    ENLV price is currently +24.69% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $24.54M
    ENLV market cap is $24.54 million

    Market Cap 3-Year Change

    -69.01%
    ENLV market cap is down -69.01% over the past 3 years

    Market Cap All-Time High

    $398.68M
    ENLV market cap is currently -93.85% below its historical high of $398.68 million

    Market Cap Sector Percentile

    24.71%
    ENLV market cap is higher than 24.71% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +10.47%
    ENLV shares outstanding is up +10.47% year-on-year

    Shares Outstanding 3-Year Change

    +31.94%
    ENLV shares outstanding is up +31.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.70
    ENLV beta is 0.70

    200-day SMA

    $1.09
    ENLV price is currently -7.56% below its 200-day simple moving average

    50-day SMA

    $1.07
    ENLV price is currently -5.23% below its 50-day simple moving average

    14-Day RSI

    36.32
    ENLV 14-day relative strength index is 36.32

    Volume

    0.45
    ENLV 30-day relative volume is 0.45

    ATR

    $0.05
    ENLV average true range is $0.05

    10-day Historical Volatility

    21.58%
    ENLV 10-day historical volatility is 21.58%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ENLV annual revenue is $0.00

    Revenue Analysts Estimate

    -
    ENLV annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    ENLV annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.69%
    ENLV annual revenue is higher than 28.69% of companies in Healthcare sector

    EPS

    EPS

    -$0.73
    ENLV annual earnings per share is -$0.73

    EPS Analysts Estimate

    -$0.52
    ENLV annual earnings per share is currently -42.12% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +53.23%
    ENLV annual earnings per share is up +53.23% year-on-year

    EPS Sector Percentile

    61.84%
    ENLV annual earnings per share is higher than 61.84% of companies in Healthcare sector

    Profit

    Gross Profit

    -$545.00K
    ENLV annual gross profit is -$545.00 thousand

    Gross Margin

    -
    ENLV annual gross profit margin value is unknown

    Operating Profit

    -$15.54M
    ENLV annual operating income is -$15.54 million

    Operating Margin

    -
    ENLV annual operating profit margin value is unknown

    Net Income

    -$15.01M
    ENLV annual net profit is -$15.01 million

    Net Margin

    -
    ENLV annual net profit margin value is unknown

    Expenses

    Total Expenses

    $15.54M
    ENLV annual total expenses is $15.54 million

    Operating Expenses

    $15.54M
    ENLV annual total operating expenses is $15.54 million

    Cost Of Goods Sold

    $545.00K
    ENLV annual cost of goods sold is $545.00 thousand

    Selling, General & Administrative Expenses

    $4.81M
    ENLV annual SG&A is $4.81 million

    Depreciation & Amortization

    $545.00K
    ENLV annual D&A is $545.00 thousand

    Interest Expense

    $0.00
    ENLV annual interest expense is $0.00

    Income Tax

    $0.00
    ENLV annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$15.54M
    ENLV annual earnings before interest & taxes is -$15.54 million

    EBITDA

    -$14.99M
    ENLV annual EBITDA is -$14.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $27.69M
    ENLV annual total assets is $27.69 million

    Non Current Assets

    $1.69M
    ENLV annual long term assets is $1.69 million

    Current Assets

    $25.99M
    ENLV annual total current assets is $25.99 million

    Cash and Cash Equivalents

    $23.61M
    ENLV annual cash & cash equivalents is $23.61 million

    Accounts Receivable

    -
    ENLV annual accounts receivable value is unknown

    Inventory

    $0.00
    ENLV annual inventory is $0.00

    Liabilities

    Total Liabilities

    $4.10M
    ENLV annual total liabilities is $4.10 million

    Long Term Liabilities

    $299.00K
    ENLV annual total long term liabilities is $299.00 thousand

    Current Liabilities

    $3.80M
    ENLV annual current liabilities is $3.80 million

    Accounts Payable

    $811.00K
    ENLV annual accounts payable is $811.00 thousand

    Debt

    Total Debt

    $534.00K
    ENLV annual total debt is $534.00 thousand

    Total Debt 1-Year Change

    -48.26%
    ENLV annual total debt is down -48.26% year-on-year

    Long Term Debt

    $299.00K
    ENLV annual long term debt is $299.00 thousand

    Short Term Debt

    $235.00K
    ENLV annual short term debt is $235.00 thousand

    Equity & Capital

    Shareholders Equity

    $23.59M
    ENLV annual stockholders equity is $23.59 million

    Book Value

    $23.59M
    ENLV annual book value is $23.59 million

    Retained Earnings

    -$127.11M
    ENLV annual retained earnings is -$127.11 million

    Working Capital

    $22.19M
    ENLV annual working capital is $22.19 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$13.01M
    ENLV annual cash from operations is -$13.01 million

    Cash From Operations 1-Year Change

    +44.7%
    ENLV annual cash from operations is up +44.7% year-on-year

    Cash From Investing

    $9.06M
    ENLV annual cash from investing is $9.06 million

    Cash From Investing 1-Year Change

    +134.89%
    ENLV annual cash from investing is up +134.89% year-on-year

    Cash From Financing

    $6.45M
    ENLV annual cash from financing is $6.45 million

    Cash From Financing 1-Year Change

    +1692.78%
    ENLV annual cash from financing is up +1692.78% year-on-year

    CAPEX

    CAPEX

    $103.00K
    ENLV annual capital expenditures is $103.00 thousand

    CAPEX 1-Year Change

    -56.36%
    ENLV annual capital expenditures is down -56.36% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$13.11M
    ENLV annual free cash flow is -$13.11 million

    Free Cash Flow 1-Year Change

    +44.82%
    ENLV annual free cash flow is up +44.82% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    ENLV annual gross profit margin value is unknown

    Operating Margin

    -
    ENLV annual operating profit margin value is unknown

    Net Margin

    -
    ENLV annual net profit margin value is unknown

    ROA & ROE

    ROA

    -46.54%
    ENLV annual return on assets is -46.54%

    ROE

    -55.95%
    ENLV annual return on equity is -55.95%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ENLV price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ENLV price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.29
    ENLV price to book ratio is 1.29

    PB Ratio Sector Percentile

    41.22%
    ENLV price to book ratio is higher than 41.22% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    ENLV price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    ENLV price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $5.40M
    ENLV enterprise value is $5.40 million

    Enterprise Value Sector Percentile

    18.05%
    ENLV enterprise value is higher than 18.05% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.36
    ENLV EV/EBITDA is -0.36

    EV/EBITDA Sector Percentile

    56.39%
    ENLV EV/EBITDA is higher than 56.39% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.84
    ENLV annual current ratio is 6.84

    Quick Ratio

    6.84
    ENLV annual quick ratio is 6.84

    Leverage

    Debt To Equity

    0.02
    ENLV annual debt to equity ratio is 0.02

    Interest Coverage Ratio

    -
    ENLV annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    ENLV piotroski f-score value is unknown

    Altman Z-Score

    -3.72
    ENLV altman z-score is -3.72

    Analyst ratings

    Recent major analysts updates

    Oct 29, 25 D. Boral Capital
    Buy
    Sep 26, 25 D. Boral Capital
    Buy
    Sep 12, 25 D. Boral Capital
    Buy
    Sep 2, 25 HC Wainwright & Co.
    Buy
    Aug 22, 25 D. Boral Capital
    Buy
    Aug 18, 25 D. Boral Capital
    Buy
    Jul 29, 25 D. Boral Capital
    Buy
    Jul 22, 25 D. Boral Capital
    Buy
    Apr 21, 25 D. Boral Capital
    Buy
    Apr 3, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with ENLV included

    Growing Shares Outstanding
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Enlivex Therapeutics Ltd.?
    • Does Enlivex Therapeutics Ltd. pay dividends?
    • What sector is Enlivex Therapeutics Ltd. in?
    • What industry is Enlivex Therapeutics Ltd. in?
    • What country is Enlivex Therapeutics Ltd. based in?
    • When did Enlivex Therapeutics Ltd. go public?
    • Is Enlivex Therapeutics Ltd. in the S&P 500?
    • Is Enlivex Therapeutics Ltd. in the NASDAQ 100?
    • Is Enlivex Therapeutics Ltd. in the Dow Jones?
    • When was Enlivex Therapeutics Ltd.'s last earnings report?
    • When does Enlivex Therapeutics Ltd. report earnings?

    What is the ticker symbol for Enlivex Therapeutics Ltd.?

    The ticker symbol for Enlivex Therapeutics Ltd. is NASDAQ:ENLV

    Does Enlivex Therapeutics Ltd. pay dividends?

    No, Enlivex Therapeutics Ltd. does not pay dividends

    What sector is Enlivex Therapeutics Ltd. in?

    Enlivex Therapeutics Ltd. is in the Healthcare sector

    What industry is Enlivex Therapeutics Ltd. in?

    Enlivex Therapeutics Ltd. is in the Biotechnology industry

    What country is Enlivex Therapeutics Ltd. based in?

    Enlivex Therapeutics Ltd. is headquartered in Israel

    When did Enlivex Therapeutics Ltd. go public?

    Enlivex Therapeutics Ltd.'s initial public offering (IPO) was on July 31, 2014

    Is Enlivex Therapeutics Ltd. in the S&P 500?

    No, Enlivex Therapeutics Ltd. is not included in the S&P 500 index

    Is Enlivex Therapeutics Ltd. in the NASDAQ 100?

    No, Enlivex Therapeutics Ltd. is not included in the NASDAQ 100 index

    Is Enlivex Therapeutics Ltd. in the Dow Jones?

    No, Enlivex Therapeutics Ltd. is not included in the Dow Jones index

    When was Enlivex Therapeutics Ltd.'s last earnings report?

    Enlivex Therapeutics Ltd.'s most recent earnings report was on November 18, 2022

    When does Enlivex Therapeutics Ltd. report earnings?

    The date for Enlivex Therapeutics Ltd.'s next earnings report has not been announced yet
    On this page